Wedbush Securities’s Acer Therapeutics Inc ACER Stock Holding History

Wedbush Securities’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-24,055	Closed	-$94K	–	1035
2019 Q2	$94K	Buy	+24,055	New	+$458K	0.01%	908

Other funds holding ACER

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wedbush Securities's ACER Position: Q3 2019 in Review

Wedbush Securities sold out of Acer Therapeutics Inc (ACER) in Q3 2019, closing a stake of 24,055 shares — an estimated $94K sold.

Wedbush Securities first reported a position in ACER in Q2 2019 and held it in 1 quarter. The position peaked at $94K in Q2 2019. 40 funds tracked by Wall St. Rank hold ACER as of Q3 2019.

Wedbush Securities reported no remaining Acer Therapeutics Inc position as of Q3 2019 after selling out during the quarter.
Wedbush Securities sold 24,055 Acer Therapeutics Inc shares in Q3 2019, an estimated $94K.
Wedbush Securities first reported a position in Acer Therapeutics Inc in Q2 2019 and held it in 1 quarter.
Wedbush Securities's Acer Therapeutics Inc position peaked at $94K in Q2 2019.
40 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q3 2019.

Based on Wedbush Securities's 13F filing for Q3 2019, filed 17 Oct 2019.